These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7884851)

  • 21. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
    Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ
    J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
    Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.
    Khan MA; Aberham C; Kao S; Akari H; Gorelick R; Bour S; Strebel K
    J Virol; 2001 Aug; 75(16):7252-65. PubMed ID: 11461998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.
    Simm M; Shahabuddin M; Chao W; Allan JS; Volsky DJ
    J Virol; 1995 Jul; 69(7):4582-6. PubMed ID: 7769728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J
    J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.
    Fujita M; Matsumoto S; Sakurai A; Doi N; Miyaura M; Yoshida A; Adachi A
    Microbes Infect; 2002 Oct; 4(12):1203-7. PubMed ID: 12467760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Sheehy AM; Gaddis NC; Choi JD; Malim MH
    Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.
    Fujita M; Sakurai A; Yoshida A; Miyaura M; Koyama AH; Sakai K; Adachi A
    J Virol; 2003 Jan; 77(2):1626-32. PubMed ID: 12502880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Vif in stability of the human immunodeficiency virus type 1 core.
    Ohagen A; Gabuzda D
    J Virol; 2000 Dec; 74(23):11055-66. PubMed ID: 11070000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermutation of HIV-1 DNA in the absence of the Vif protein.
    Lecossier D; Bouchonnet F; Clavel F; Hance AJ
    Science; 2003 May; 300(5622):1112. PubMed ID: 12750511
    [No Abstract]   [Full Text] [Related]  

  • 33. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages.
    Gabuzda DH; Li H; Lawrence K; Vasir BS; Crawford K; Langhoff E
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):908-15. PubMed ID: 7519673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Vif during HIV-1 infection: interaction with novel host cellular factors.
    Lake JA; Carr J; Feng F; Mundy L; Burrell C; Li P
    J Clin Virol; 2003 Feb; 26(2):143-52. PubMed ID: 12600646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    Kiernan RE; Ono A; Englund G; Freed EO
    J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.
    Simon JH; Miller DL; Fouchier RA; Malim MH
    Virology; 1998 Sep; 248(2):182-7. PubMed ID: 9721227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.
    Sakai H; Shibata R; Sakuragi J; Sakuragi S; Kawamura M; Adachi A
    J Virol; 1993 Mar; 67(3):1663-6. PubMed ID: 8437236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions.
    Baraz L; Kotler M
    Curr Med Chem; 2004 Jan; 11(2):221-31. PubMed ID: 14754418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.